24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

One particularly interesting case involves a patient with a clinical diagnosis<br />

<strong>of</strong> autosomal recessive multi-minicore disease in whom we<br />

found three RYR1 mutations - two missense mutations previously reported<br />

as pathogenic and one previously unreported three base pair<br />

deletion .<br />

In addition to causing congenital myopathy, mutations in certain regions<br />

<strong>of</strong> the RYR1 gene are also associated with malignant hyperthermia<br />

susceptibility (MHS) and it is important that the implications <strong>of</strong> this<br />

are clearly explained to other family members .<br />

P05.174<br />

Role <strong>of</strong> Attct repeat interruptions in spinocerebellar ataxia<br />

type 10<br />

I. Alonso 1 , T. Almeida 1 , L. B. Jardim 2 , O. Artigalas 2 , M. L. Saraiva-Pereira 2 , T.<br />

Matsuura 3 , J. Sequeiros 1,4 , I. Silveira 1 ;<br />

1 UnIGENe - IBMC, Univ. Porto, Porto, Portugal, 2 Hosp. Clinicas de Porto<br />

Alegre, Porto Alegre, Brazil, 3 Center for Neurological Diseases and Cancer,<br />

Nagoya University Graduate School <strong>of</strong> Medicine, Nagoya, Japan, 4 ICBAS, Univ.<br />

Porto, Porto, Portugal.<br />

Spinocerebellar ataxia type 10 (SCA10) is a dominant neurological<br />

disease, caused by the expansion <strong>of</strong> an (ATTCT)n in intron 9 <strong>of</strong><br />

ATXN10, <strong>of</strong> still unknown function. SCA10 was first described in Mexican<br />

families with ataxia and seizures . We have previously described<br />

an expansion <strong>of</strong> the ATTCT repeat in two Brazilian families presenting<br />

ataxia without seizures . We found reduced penetrance alleles <strong>of</strong> 360-<br />

370 repeats, in elderly asymptomatic subjects .<br />

To investigate a previous hypothesis <strong>of</strong> interruptions in the (ATTCT)n<br />

tract, functioning as a disease modifier, we assessed the interruption<br />

in another family with ataxia and seizures, and more than 2000 ATTCT<br />

units .<br />

By a modified PCR technique, an abnormal discontinuous ladder, exceeding<br />

the range observed for normal alleles, was detected in this<br />

Brazilian family, presenting progressive cerebellar ataxia with associated<br />

seizures and onset during or after the 3 rd decade . This suggested<br />

the presence <strong>of</strong> interruptions within the ATTCT expansion. Modified<br />

PCR products <strong>of</strong> patients showing an interrupted pattern were agarose-gel<br />

purified and cloned with TOPO TA cloning kit for sequencing<br />

analysis and determination <strong>of</strong> the interrupted motif .<br />

In this family, the ATTCT repeat seems to be interrupted by a large<br />

stretch, unrelated to the repeat sequence, and patients show progressive<br />

cerebellar ataxia with associated seizures . In contrast, the previous<br />

SCA10 families identified by us, showed cerebellar ataxia without<br />

seizures, caused by the expansion <strong>of</strong> uninterrupted ATTCT tracts . This<br />

newly identified family reinforces the hypothesis that interruptions in<br />

the (ATTCT)n tract function as a disease modifier.<br />

P05.175<br />

Ribosomal frameshifting on expanded ATXN transcripts: a<br />

Drosophila model<br />

C. Gaspar 1 , S. Stochmanski 1 , J. Laganière 1 , M. Therrien 1 , D. Rochefort 1 , D.<br />

Van Meyel 2 , G. A. Rouleau 1 ;<br />

1 Centre <strong>of</strong> Excellence in Neuromics, Université de Montréal, Montreal, QC,<br />

Canada, 2 Centre for Research in Neuroscience, McGill University, Montreal,<br />

QC, Canada.<br />

Background: Spinocerebellar ataxia type 3 (SCA3) is caused by the<br />

expansion <strong>of</strong> a coding CAG repeat in the ATXN3 gene . We have previously<br />

shown that the expanded CAG repeat in SCA3 is prone to -1<br />

ribosomal frameshifting, leading to the production and aggregation <strong>of</strong><br />

proteins containing polyalanine stretches . These frameshifted molecules<br />

confer increased toxicity to cells when compared to constructs<br />

containing expanded CAA repeats, which code for polyglutamine in the<br />

main frame but lack the ability to frameshift into an alanine frame . Anisomycin<br />

(a ribosome interacting antibiotic that reduces -1 frameshifting)<br />

decreases frameshifting in expanded CAG tracts and ameliorates<br />

the cellular toxic phenotype .<br />

Aims: To model expCAG repeat -1 frameshifting in vivo; to assess the<br />

contribution <strong>of</strong> -1 frameshifting to expCAG toxicity in the fly.<br />

Methods: Full-length ATXN3 Drosophila transgenic lines carrying either<br />

wtCAG, expCAG or expCAA constructs containing epitope tags in<br />

the three possible reading frames were generated and comparatively<br />

analysed .<br />

Results: We show that: (1) transgenic expression <strong>of</strong> expCAG ATXN3<br />

constructs is deleterious in the fly; (2) transgenic expression <strong>of</strong> exp-<br />

CAA ATXN3 constructs, despite adequate levels <strong>of</strong> protein expression,<br />

is not toxic; (3) -1 frameshifting occurs in Drosophila and is restricted to<br />

the expanded CAG transgenic lines .<br />

Conclusions: We propose that -1 ribosomal frameshifting is a major<br />

contributor to the toxicity observed in expanded CAG repeat diseases .<br />

This novel pathological mechanism may open new therapeutic opportunities<br />

for these diseases .<br />

P05.176<br />

mutation analysis <strong>of</strong> the scN1A gene and genotype-phenotype<br />

correlations in Bulgarian epilepsy patients<br />

I. Yordanova 1,2 , L. Claes 3 , I. Ivanov 4 , A. Suls 3 , I. Litvinenko 5 , P. Dimova 6 , D.<br />

Hristova 5 , V. Bozinova 6 , I. Kremensky 1,2 , P. De Jonghe 3 , A. Jordanova 2,3 ;<br />

1 National <strong>Genetics</strong> Laboratory, S<strong>of</strong>ia, Bulgaria, 2 Molecular Medicine Center,<br />

Medical University, S<strong>of</strong>ia, Bulgaria, 3 VIB Department <strong>of</strong> Molecular <strong>Genetics</strong>,<br />

University <strong>of</strong> Antwerp, Antwerpen, Belgium, 4 Department <strong>of</strong> Pediatrics, Medical<br />

University, Plovdiv, Bulgaria, 5 Department <strong>of</strong> Pediatrics, Medical University,<br />

S<strong>of</strong>ia, Bulgaria, 6 Department <strong>of</strong> Neurology, Medical University, S<strong>of</strong>ia, Bulgaria.<br />

Epilepsy is a common neurological disease, affecting more than 1%<br />

<strong>of</strong> people from any age, gender and ethnical origin . Mutations in the<br />

alpha1-subunit (α1) <strong>of</strong> the neuronal voltage gated sodium channel<br />

Na v 1 .1, are associated with generalized epilepsy with febrile seizures<br />

plus (GEFS+) and severe myoclonic epilepsy in infancy (SMEI) . It is<br />

encoded by 26 exons <strong>of</strong> the SCN1A gene on chromosome 2q24 .<br />

We performed a mutation analysis <strong>of</strong> SCN1A in 28 patients with<br />

GEFS+, 20 with SMEI and 62 with other types <strong>of</strong> infantile epilepsy .<br />

Genomic DNA was extracted from peripheral blood lymphocytes using<br />

a standard sodium chloride precipitation method . The SCN1A point<br />

mutation screening included PCR analysis followed by direct sequencing<br />

<strong>of</strong> all exons and exon-intron boundaries <strong>of</strong> the gene . In addition, all<br />

patients were analyzed for exonic deletions and duplications by MAQ<br />

assay .<br />

We identified 11 disease-causing mutations, including 6 missense,<br />

2 nonsense, 1 splice-site mutation and 2 single base deletions . Two<br />

missense and all truncating mutations were found in SMEI patients,<br />

consistent with the severity <strong>of</strong> the epilepsy phenotype . Four GEFS+<br />

patients carried a missense mutation. All mutations we identified had<br />

not been reported in the literature. This is the first large scale study <strong>of</strong><br />

SCN1A gene analysis in Bulgarian epilepsy patients .<br />

In our sample, a mutation was identified in 23% <strong>of</strong> patients with GEFS+<br />

or SMEI, and none in the other epilepsy patients . This nicely illustrates<br />

that GEFS+ and SMEI are part <strong>of</strong> a continuous spectrum <strong>of</strong> fever associated<br />

epilepsy phenotypes caused by mutations in SCN1A .<br />

P05.177<br />

KPQ del in SCN5a gene in two different types <strong>of</strong> SCD in one<br />

family<br />

S. Saber 1 , K. Banihashemi 1 , M. Eftekharzadeh 2 , M. KhosroHeidari1 1 , m. a.<br />

SadrAmeli 3 , A. F. Fazelifar 3 , M. Haghjoo 3 , m. Houshmand 4 , E. V. Zaklyazminskaya<br />

5 ;<br />

1 Special medical center genetic lab ward , Russian Academy <strong>of</strong> Science DNA<br />

lab, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Tehran clinic arrhythmia center, Tehran,<br />

Islamic Republic <strong>of</strong> Iran, 3 Heart center shahid Rajaee hospital electrophysiology<br />

ward, Tehran, Islamic Republic <strong>of</strong> Iran, 4 Special medical center genetic lab<br />

ward, Tehran, Islamic Republic <strong>of</strong> Iran, 5 Russian Academy <strong>of</strong> Science DNA lab,<br />

Moscow, Russian Federation.<br />

Cardiac action potentials are generated and propagated through the<br />

coordinated activity <strong>of</strong> multiple ion channels, including voltage-gated<br />

sodium channels, calcium channels and potassium channels . Mutations<br />

in genes encoding these channels cause familial arrhythmias .<br />

Heart rhythm disturbances constituent some inherited syndromes any<br />

kind <strong>of</strong> genetic nature<br />

Many kinds <strong>of</strong> arrhythmia caused SCD (sudden cardiac death) and<br />

the prevalence <strong>of</strong> SCD is 1: 1000 individuals . Some <strong>of</strong> SCDs were<br />

caused by Na channelopathy such as LQT3 and Brugada Syn these<br />

are two <strong>of</strong> main caused <strong>of</strong> sudden cardiac death in young people with<br />

out any detectable cardiac abnormality with routine tests and we know<br />

that Brugada syndrome was caused by loss <strong>of</strong> function <strong>of</strong> Na channel<br />

and LQT3 was caused by gain <strong>of</strong> function Na channel in heart . . We<br />

can check SCN5a gene for ruling out <strong>of</strong> this gene as a main gene<br />

<strong>of</strong> Na channelopathy in heart arrhythmias . We check by SSCP and<br />

Sequencing this gene . We checked SCN5A in a family with 11 affected<br />

person that approved by ECG and EPS study and some persons

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!